Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ThromboGenics NV

+ Add to Watchlist


5.3010 EUR 0.0190 0.36%

As of 11:35:00 ET on 03/30/2015.

Company Profile for ThromboGenics NV (THR)

ThromboGenics NV is a biopharmaceutical company focused on the development of therapeutics for conditions related to the vascular system. The Company is focused on developing medicines to treat visual disorders, cardiovascular diseases, and cancer, conditions which result from abnormalities to the vascular system.

Contact Information

ThromboGenics NV

Gaston Geenslaan 1
Phone: 32-16-75-13-10
Fax: 32-16-75-13-11

Key Executives for ThromboGenics NV (THR)

Gustaaf Van Reet "Staf"ChairmanPatrik De HaesCEO/Executive Director
Dominique VanfleterenChief Financial OfficerKoen KasChief Scientific Officer
Laurence RaemdonckHead:Human ResourcesAndy De DeeneHead:Product Dev
David PearsonHead:Corporate DevAniz GirachHead:Clinical Dev
Paul De NijsHead:Market Access

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil